# BTBD8

## Overview
BTBD8 is a gene that encodes the BTB domain-containing protein 8, which is involved in several critical cellular processes, including synaptic vesicle trafficking, neuronal development, and synaptic plasticity. The protein is associated with clathrin-coated vesicles, playing a significant role in endocytosis and intracellular transport, particularly within intestinal epithelial cells where it helps maintain barrier integrity by regulating tight junction proteins such as ZO-1 and Occludin (Yang2024Btbd8). BTBD8's expression is notably higher in the intestinal epithelium compared to other cell types, underscoring its specialized function in epithelial cell activity and intestinal stem cell regulation (Yang2024Btbd8). The gene's involvement in these processes extends to its potential impact on organismal physiology and its implication in various diseases, including inflammatory bowel disease, malignant meningioma, early-onset dementia, and multiple myeloma (Yang2024Btbd8; Smetana2014GenomeWide; Huo2023Prognostic; RamosCampoy2024GenomeWide).

## Function
BTBD8, also known as APache, is a gene that encodes a protein involved in various cellular processes, including synaptic vesicle trafficking, neuronal development, and synaptic plasticity. It is associated with clathrin-coated vesicles, which are crucial for endocytosis and intracellular transport (Yang2024Btbd8). In the context of intestinal epithelial cells, BTBD8 plays a significant role in maintaining intestinal barrier integrity. It is involved in the regulation of tight junction proteins such as ZO-1 and Occludin, which are essential for the structural integrity of the intestinal barrier (Yang2024Btbd8). BTBD8 is suggested to promote the endocytosis of Occludin, thereby modulating its expression in tight junctions (Yang2024Btbd8).

In healthy human cells, BTBD8 is expressed at higher levels in the intestinal epithelium compared to immune and stromal cells, indicating its specific role in epithelial cell function (Yang2024Btbd8). The gene's involvement in cellular processes extends to influencing intestinal stem cell activity, which is crucial for epithelial regeneration and maintaining the integrity of the intestinal lining (Yang2024Btbd8). These functions highlight BTBD8's role in cellular differentiation and development, impacting organismal physiology.

## Clinical Significance
BTBD8 has been implicated in several diseases and conditions through its altered expression or interactions. In inflammatory bowel disease (IBD), particularly colitis, BTBD8 deficiency has been shown to enhance intestinal barrier function and suppress inflammation, suggesting a protective role against colitis. This is achieved through increased expression of tight junction proteins and reduced pro-inflammatory cytokines, indicating that BTBD8 could be a potential therapeutic target for IBD treatment (Yang2024Btbd8).

In the context of malignant meningioma, BTBD8 is identified as one of the genes associated with malignant progression. Its expression level is part of a prognostic model for predicting patient outcomes, with lower expression linked to reduced risk of progression (Huo2023Prognostic). 

BTBD8 is also involved in early-onset dementia, where hypermethylation of the gene is observed in patients with frontotemporal dementia, suggesting a potential role in the disease's pathogenesis (RamosCampoy2024GenomeWide).

In multiple myeloma, deletions in the chromosomal region containing BTBD8 have been detected, although the specific clinical significance of these deletions remains unclear (Smetana2014GenomeWide). These findings highlight the diverse roles of BTBD8 in various diseases.

## Interactions
BTBD8 is involved in protein interactions that influence various cellular processes. It has been shown to interact with AP2, an adaptor protein involved in clathrin-mediated endocytosis. This interaction suggests that BTBD8 plays a role in promoting the endocytosis of tight junction proteins such as Occludin, thereby modulating their expression in intestinal epithelial cells (Yang2024Btbd8). The interaction with AP2 is significant in the context of intestinal barrier function, as BTBD8 deficiency leads to fewer endocytic vesicles in intestinal epithelial cells, indicating a reduction in endocytosis activity (Yang2024Btbd8).

In a separate study, BTBD8 expression was found to decrease when p53 and p60-katanin were co-expressed, suggesting that BTBD8 might be involved in pathways related to clathrin-mediated endocytosis and neuronal development (Korulu2024Coexpression). However, specific details about direct physical interactions between BTBD8 and other proteins or nucleic acids in this context are not provided. Overall, BTBD8's interactions appear to be crucial for its role in cellular processes such as endocytosis and potentially in the regulation of inflammation and intestinal barrier integrity.


## References


[1. (Yang2024Btbd8) Xiaoqiong Yang, Zichan He, Qiman Dong, Shanshan Nai, Xiaowei Duan, Jiayu Yu, Nannan Zhao, Xiaoling Du, and Lingyi Chen. Btbd8 deficiency reduces susceptibility to colitis by enhancing intestinal barrier function and suppressing inflammation. Frontiers in Immunology, March 2024. URL: http://dx.doi.org/10.3389/fimmu.2024.1382661, doi:10.3389/fimmu.2024.1382661. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2024.1382661)

[2. (Smetana2014GenomeWide) Jan Smetana, Jan Frohlich, Romana Zaoralova, Vladimira Vallova, Henrieta Greslikova, Renata Kupska, Pavel Nemec, Aneta Mikulasova, Martina Almasi, Ludek Pour, Zdenek Adam, Viera Sandecka, Lenka Zahradová, Roman Hajek, and Petr Kuglik. Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-cgh technique: a czech multicenter experience. BioMed Research International, 2014:1–9, 2014. URL: http://dx.doi.org/10.1155/2014/209670, doi:10.1155/2014/209670. This article has 17 citations and is from a poor quality or predatory journal.](https://doi.org/10.1155/2014/209670)

[3. (Korulu2024Coexpression) Şirin Korulu. Co-expression of p53 and p60-katanin shapes transcriptome dynamics. Trakya University Journal of Natural Sciences, October 2024. URL: http://dx.doi.org/10.23902/trkjnat.1521899, doi:10.23902/trkjnat.1521899. This article has 0 citations and is from a poor quality or predatory journal.](https://doi.org/10.23902/trkjnat.1521899)

[4. (RamosCampoy2024GenomeWide) Oscar Ramos-Campoy, Aina Comas-Albertí, David Hervás, Sergi Borrego-Écija, Beatriz Bosch, Juan Sandoval, Laura Fort-Aznar, Fermín Moreno-Izco, Guadalupe Fernández-Villullas, Laura Molina-Porcel, Mircea Balasa, Albert Lladó, Raquel Sánchez-Valle, and Anna Antonell. Genome-wide dna methylation in early-onset-dementia patients brain tissue and lymphoblastoid cell lines. International Journal of Molecular Sciences, 25(10):5445, May 2024. URL: http://dx.doi.org/10.3390/ijms25105445, doi:10.3390/ijms25105445. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25105445)

[5. (Huo2023Prognostic) Xulei Huo, Lairong Song, Ke Wang, Hongyi Wang, Da Li, Huan Li, Wei Wang, Yali Wang, Lei Chen, Zongmao Zhao, Liang Wang, and Zhen Wu. Prognostic factors and doxorubicin involved in malignant progression of meningioma. Scientific Reports, April 2023. URL: http://dx.doi.org/10.1038/s41598-023-28996-0, doi:10.1038/s41598-023-28996-0. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-28996-0)